LETTER TO THE EDITOR Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome

摘要

N Kroger et al recently reported the results of a retrospective analysis of 65 patients undergoing autologous stem cell transplantation for therapy-related acute myeloid leukemia (t-AML) and myelodysplastic syndrome (t-MDS). The authors analyzed European bone marrow transplantation registry data and showed that the Kaplan-Meier estimates of the probability of 3-year overall and disease-free survival were 35 and 32%, respectively. These figures exceed the results obtained with allogeneic stem cell transplantation and support the autologous approach as an alternative for patients with t-AML/t-MDS.